Skip to search.
 FTSE 100 Down 1.27%

Alkermes plc (ALKS)

-NasdaqGS
40.36 Up 0.61(1.53%) 2 May 21:00
|After Hours: : 40.36 0.00 (0.00%) 21:39
Prev Close:39.75
Open:39.79
Bid:40.00 x 100
Ask:40.43 x 500
1y Target Est:44.40
Beta:2.10494
Earnings Date:28 Jul - 1 Aug (Est.)
Day's Range:38.64 - 40.36
52wk Range:27.14 - 80.71
Volume:846,197
Avg Vol (3m):1,686,520
Market Cap:6.10b
P/E (ttm):N/A
EPS (ttm):-1.52
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALKSUp 1.53%6.10b
LLYUp 1.62%81.59b
GSKUp 0.89%104.76b
ABTDown 0.13%57.09b

Key Statistics

Forward P/E (1 yr):161.44
P/S (ttm):9.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.48
Quarterly EPS Est (Jun-16) :-0.14
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):3.58

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products that are designed to address unmet medical needs of patients in various therapeutic areas worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback